We’ve recently updated our valuation analysis.

SuRo Capital Valuation

Is SSSS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

[object Object] Score

3/6

Valuation Score 3/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SSSS?

Other financial metrics that can be useful for relative valuation.

SSSS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue60.3x
Enterprise Value/EBITDAn/a
PEG Ration/a

Price to Book Ratio vs Peers

How does SSSS's PB Ratio compare to its peers?

The above table shows the PB ratio for SSSS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average23960.8x
HGBL Heritage Global
2.3x34.3%US$87.5m
AIB AIB Acquisition
67800xn/aUS$114.4m
MCAC Monterey Capital Acquisition
23209.3xn/aUS$116.1m
DUET DUET Acquisition
4831.7xn/aUS$113.1m
SSSS SuRo Capital
0.5xn/aUS$109.1m

Price-To-Book vs Peers: SSSS is good value based on its Price-To-Book Ratio (0.5x) compared to the peer average (23960.8x).


Price to Earnings Ratio vs Industry

How does SSSS's PE Ratio compare vs other companies in the US Capital Markets Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a12.5%
n/an/an/a

Price-To-Book vs Industry: SSSS is expensive based on its Price-To-Book Ratio (0.5x) compared to the US Capital Markets industry average (-26.7x)


Price to Book Ratio vs Fair Ratio

What is SSSS's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SSSS PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio0.5x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate SSSS's Price-To-Book Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of SSSS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SSSS ($3.85) is trading below our estimate of fair value ($12.94)

Significantly Below Fair Value: SSSS is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SSSS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$3.85
US$7.75
+101.3%
19.6%US$9.50US$6.00n/a4
Nov ’23US$4.09
US$9.50
+132.3%
24.1%US$12.00US$6.00n/a4
Oct ’23US$3.87
US$10.25
+164.9%
12.7%US$12.00US$9.00n/a4
Sep ’23US$6.34
US$10.25
+61.7%
12.7%US$12.00US$9.00n/a4
Aug ’23US$6.62
US$13.63
+105.8%
13.1%US$16.00US$11.00n/a4
Jul ’23US$6.48
US$13.63
+110.3%
13.1%US$16.00US$11.00n/a4
Jun ’23US$7.48
US$13.63
+82.2%
13.1%US$16.00US$11.00n/a4
May ’23US$8.18
US$14.38
+75.7%
6.7%US$16.00US$13.50n/a4
Apr ’23US$8.64
US$14.38
+66.4%
6.7%US$16.00US$13.50n/a4
Mar ’23US$11.46
US$17.69
+54.3%
10.1%US$20.00US$15.00n/a4
Feb ’23US$12.31
US$17.69
+43.7%
10.1%US$20.00US$15.00n/a4
Jan ’23US$12.95
US$17.94
+38.5%
7.9%US$20.00US$16.00n/a4
Dec ’22US$12.11
US$17.94
+48.1%
7.9%US$20.00US$16.00US$4.074
Nov ’22US$14.79
US$18.13
+22.5%
7.9%US$20.00US$16.00US$4.094
Oct ’22US$12.86
US$18.13
+40.9%
7.9%US$20.00US$16.00US$3.874
Sep ’22US$13.07
US$18.13
+38.7%
7.9%US$20.00US$16.00US$6.344
Aug ’22US$12.21
US$19.38
+58.7%
5.6%US$20.00US$17.50US$6.624
Jul ’22US$13.36
US$19.38
+45.0%
5.6%US$20.00US$17.50US$6.484
Jun ’22US$13.49
US$20.00
+48.3%
0%US$20.00US$20.00US$7.484
May ’22US$14.55
US$19.63
+34.9%
3.3%US$20.00US$18.50US$8.184
Apr ’22US$14.11
US$17.33
+22.8%
5.9%US$18.50US$16.00US$8.643
Mar ’22US$12.97
US$16.17
+24.6%
6.4%US$17.50US$15.00US$11.463
Feb ’22US$15.01
US$16.17
+7.7%
6.4%US$17.50US$15.00US$12.313
Jan ’22US$13.09
US$15.33
+17.1%
3.1%US$16.00US$15.00US$12.953
Dec ’21US$12.06
US$15.33
+27.1%
3.1%US$16.00US$15.00US$12.113

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies